Alpha-GPC is a highly bioavailable form of choline, an essential nutrient important for various bodily functions. In the brain, Alpha-GPC crosses the blood-brain barrier and serves as a precursor to acetylcholine, a neurotransmitter involved in memory, learning, and overall cognitive processing. This mechanism is thought to contribute to its cognitive-enhancing effects. Beyond its cognitive roles, Alpha-GPC is researched for its impact on physical performance. It may help increase power output and strength by supporting neuromuscular function and healthy growth hormone secretion. This makes it a frequent choice for those looking to optimize their physical capabilities. As a non-botanical compound, Alpha-GPC is common in supplements designed to improve focus and exercise performance. Research continues into its efficacy and safety, with a generally good safety profile when used appropriately.
No public comparison lists found.
No published studies for this goal yet.
Alpha-GPC may improve cognitive symptoms in people with dementia or other cognitive impairment. The available research is more supportive in these clinical settings than in healthy adults, where limited findings do not establish lasting brain-health benefits or prevention of decline.
Alpha-GPC has improved cognitive symptoms in some people with dementia or other cognitive impairments, including when added to medication. These findings do not establish sharper thinking in healthy people or show that Alpha-GPC prevents progression to dementia.
Alpha-GPC may briefly improve some aspects of attention in healthy, physically trained men, but the evidence is preliminary. Benefits were limited to selected cognitive tasks, so better everyday focus or a lasting improvement in mental performance is not established.
Alpha-GPC may improve some aspects of attention on cognitive tests, but the available evidence does not establish a productivity boost. Results in healthy men were selective, with no clear improvement in working memory or attention across all tests.
Alpha-GPC has limited evidence for mood support when added to donepezil in people with Alzheimer's disease. Depressive symptoms improved in that treatment setting, but the available research does not establish a mood benefit from Alpha-GPC alone or in otherwise healthy people.
Up to five highest-ranked published examples per goal. Study counts and charts include all published studies for the connection.
